Siga Technologies (SIGA) Cash & Equivalents (2010 - 2025)
Siga Technologies' (SIGA) quarterly Cash & Equivalents came in at $155.0 million in Q4 2025, little changed YoY from $155.4 million in Q4 2024, and down 9.88% on a QoQ basis from $172.0 million in Q3 2025.
Siga Technologies (SIGA) Cash & Equivalents (2010 - 2025) Analysis & Trends
Siga Technologies (SIGA) has 16 years of Cash & Equivalents data on file, last reported at $155.0 million in Q4 2025.
- Quarterly Cash & Equivalents changed 0.28% year-over-year to $155.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $155.0 million (changed 0.28% YoY) and the FY2025 annual result came in at $155.0 million, changed 0.28% from the prior year.
- Cash & Equivalents declined to $155.0 million in Q4 2025, from $172.0 million in the prior quarter.
- In the past five years, Cash & Equivalents ranged from a high of $182.5 million in Q2 2025 to a low of $71.1 million in Q3 2023.
- A 5-year average of $123.4 million and a median of $112.1 million in 2022 frame the typical range for Cash & Equivalents.
- Annual changes were most pronounced in 2021 — Cash & Equivalents soared 85.59% — and 2023, when it tumbled 35.2%.
- Tracing SIGA's Cash & Equivalents over 5 years: stood at $103.1 million in 2021, then slipped by 4.22% to $98.8 million in 2022, then jumped by 51.98% to $150.1 million in 2023, then climbed by 3.5% to $155.4 million in 2024, then declined by 0.28% to $155.0 million in 2025.
- The last three Cash & Equivalents figures came in at $155.0 million (Q4 2025), $172.0 million (Q3 2025), and $182.5 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | 1.11 Bn |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.33 Bn | 2.15 Bn | 3.66 Bn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 1.48 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 2.89 Bn |
| 5 | United Therapeutics | 22.15 Bn | 19.48 Bn | 683.80 Mn | 1.80 Bn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 886.50 Mn |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn | 332.40 Mn |
| 8 | Elanco Animal Health | 11.74 Bn | 11.21 Bn | 798.00 Mn | 530.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | 164.00 Mn |
| 10 | Siga Technologies | 213.38 Mn | 58.42 Mn | - | 154.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 154.97 Mn |
| Sep 30, 2025 | 171.96 Mn |
| Jun 30, 2025 | 182.46 Mn |
| Mar 31, 2025 | 162.27 Mn |
| Dec 31, 2024 | 155.40 Mn |
| Sep 30, 2024 | 99.27 Mn |
| Jun 30, 2024 | 106.95 Mn |
| Mar 31, 2024 | 143.87 Mn |
| Dec 31, 2023 | 150.15 Mn |
| Sep 30, 2023 | 71.11 Mn |
| Jun 30, 2023 | 76.21 Mn |
| Mar 31, 2023 | 115.68 Mn |
| Dec 31, 2022 | 98.79 Mn |
| Sep 30, 2022 | 109.75 Mn |
| Jun 30, 2022 | 114.53 Mn |
| Mar 31, 2022 | 153.26 Mn |
| Dec 31, 2021 | 103.14 Mn |
| Sep 30, 2021 | 92.82 Mn |
| Jun 30, 2021 | 98.49 Mn |
| Mar 31, 2021 | 106.53 Mn |